$IMRX 3 SEC Filings

Filed On	Filing
16 Jul 2026	Form 3: Gengos Andrew, Chief Financial Officer Holds 225,000 shares of Class A Common Stock
24 Mar 2025	Form 3: Matushansky Igor, Chief Medical Officer No securities owned
12 Mar 2024	Form 3: Schall Thomas J., Director No securities owned
24 Apr 2023	Form 3: Cormorant Asset Management, Lp, 10% owner and 3 others Holds 4,204,364 shares of Class A Common Stock
03 Apr 2023	Form 3: Brakewood Harold Eugene, Chief Business Officer No securities owned
20 Oct 2022	Form 3: Neufeld Leah R, Chief People Officer No securities owned
11 Aug 2022	Form 3: Morales Mallory, Vice President, Finance Holds 2,434 shares of Class A Common Stock
18 Jan 2022	Form 3: Hausman Diana, Director No securities owned
29 Jul 2021	Form 3: Feinberg Peter, Director Holds 123,753 shares of Class A Common Stock
29 Jul 2021	Form 3: Amin Biren, CFO, Treasurer
29 Jul 2021	Form 3: Keating Laurie, Director
29 Jul 2021	Form 3: Carpenter Robert J, Director Holds 606,666 shares of Class A Common Stock
29 Jul 2021	Form 3: Barrett Scott, Chief Medical Officer
29 Jul 2021	Form 3: Zeskind Benjamin J., Director Holds 2,549,072 shares of Class A Common Stock
29 Jul 2021	Form 3: Hall Brett Matthew, Chief Scientific Officer
29 Jul 2021	Form 3: Bookman Michael, General Counsel and Secretary No securities owned
29 Jul 2021	Form 3: Berman Ann E, Director No securities owned
29 Jul 2021	Form 3: Cormorant Asset Management, Lp, 10% owner and 3 others

Comments